Clinicopathologic characteristics and management trends of cutaneous invasive and in situ melanoma in older patients: a retrospective analysis of the National Cancer Data Base

Conclusion: Older patients with melanoma are less likely to receive care in academic centers, undergo wide excision for stage I–III disease and receive systemic therapy for stage III–IV disease. Particularly, the utilization of systemic therapy is markedly low. This disparity is particularly important with the availability of less intense more effective therapies.

http://tam.sagepub.com/cgi/content/abstract/7/1/4?rss=1

Source: Therapeutic Advances in Medical Oncology - December 12, 2014 Category: Cancer & Oncology Authors: Bhatt, V. R., Shrestha, R., Krishnamurthy, J., Mosalpuria, K., Loberiza, F. R., Ganti, A. K., Silberstein, P. T. Tags: Original Research Source Type: research